LEADER 01078nam0-22003371i-450- 001 990003794290403321 005 20061019142223.0 035 $a000379429 035 $aFED01000379429 035 $a(Aleph)000379429FED01 035 $a000379429 100 $a20030910d1974----km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $a<>sistema mondiale della droga$ela tossicomania come prodotto del capitalismo internazionale$fCatherine Lamour, MichelR. Lamberti$gtraduzione di Roberto Long 205 $a[2. ed.] 210 $aTorino$cEinaudi$d1974 215 $avi, 307 p.$cc. geogr., tab.$d18 cm 225 1 $aNuovo politecnico$v61 300 $aTrad. di: Les grandes manoeuvres de l'opium 610 0 $aDroga$aProduzione e traffico 676 $a363.45 700 1$aLamour,$bCatherine$0235114 702 1$aLamberti,$bMichel R. 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003794290403321 952 $a363.45 LAM1$b3303$fBFS 959 $aBFS 996 $aSistema mondiale della droga$9506720 997 $aUNINA LEADER 03436nam 22006615 450 001 9910298345703321 005 20200703071151.0 010 $a3-319-07989-1 024 7 $a10.1007/978-3-319-07989-9 035 $a(CKB)3710000000168299 035 $a(EBL)1783098 035 $a(SSID)ssj0001295345 035 $a(PQKBManifestationID)11719457 035 $a(PQKBTitleCode)TC0001295345 035 $a(PQKBWorkID)11342383 035 $a(PQKB)10151326 035 $a(MiAaPQ)EBC1783098 035 $a(DE-He213)978-3-319-07989-9 035 $a(PPN)179923226 035 $a(EXLCZ)993710000000168299 100 $a20140707d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAtlas of Biomarkers for Alzheimer's Disease /$fby Manuel Menéndez González 205 $a1st ed. 2014. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2014. 215 $a1 online resource (43 p.) 300 $aDescription based upon print version of record. 311 $a1-322-13710-2 311 $a3-319-07988-3 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aPreface -- Introduction: What is a biomarker? Diagnosis and Biomarkers of Alzheimer Disease -- Key Concepts -- Classification of Biomarkers for AD -- Rational Use of Biomarkers for Alzheimer's in the Clinical Setting -- Diagnostic Algorithms. 330 $aA lot of research on biomarkers for Alzheimer is being done in the last few decades. The aim of these studies is to find some method to ease the diagnosis of Alzheimers as early as possible. Such methods are a range of blood or CSF tests on one hand and several types of neuroimaging scans on the other. Many of the images coming both from laboratory and neuroimaging are very visual and illustrative. These images, accompanied by a short description, can perfectly explain the main results and usefulness of every biomarker. The objective of this book would be to summarize the most important studies made in this field. Few publications have systematically compiled results on this topic and only one as an atlas. Readers would be interested in this publication because it allows reviewing the current status of research by handily visualizing the results. 606 $aNeurosciences 606 $aLaboratory medicine 606 $aMolecular biology 606 $aNeurochemistry 606 $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006 606 $aLaboratory Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B15007 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aNeurochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/B18010 615 0$aNeurosciences. 615 0$aLaboratory medicine. 615 0$aMolecular biology. 615 0$aNeurochemistry. 615 14$aNeurosciences. 615 24$aLaboratory Medicine. 615 24$aMolecular Medicine. 615 24$aNeurochemistry. 676 $a610.724 700 $aMenéndez González$b Manuel$4aut$4http://id.loc.gov/vocabulary/relators/aut$01058250 906 $aBOOK 912 $a9910298345703321 996 $aAtlas of Biomarkers for Alzheimer's Disease$92498402 997 $aUNINA